-
1
-
-
0031985198
-
Multiple myeloma: Increasing evidence for a multistep transformation process
-
Hallek M, Bergsagel PL, Anderson KC: Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 91:3-21, 1998
-
(1998)
Blood
, vol.91
, pp. 3-21
-
-
Hallek, M.1
Bergsagel, P.L.2
Anderson, K.C.3
-
2
-
-
0027359827
-
WAF 1, a potential mediator of p53 tumor suppression
-
El-Deiry WS, Tokino T, Velculescu VE, et al: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825, 1993
-
(1993)
Cell
, vol.75
, pp. 817-825
-
-
El-Deiry, W.S.1
Tokino, T.2
Velculescu, V.E.3
-
3
-
-
0027244853
-
The p53-mdm-2 autoregulatory feedback loop
-
Wu X, Bayle JH, Olson D, et al: The p53-mdm-2 autoregulatory feedback loop. Genes Dev 7:1126-1132, 199 3
-
Genes Dev
, vol.7
, pp. 1126-1132
-
-
Wu, X.1
Bayle, J.H.2
Olson, D.3
-
4
-
-
0026437723
-
p53 and RAS gene mutations in multiple myeloma
-
Portier M, Moles JP, Mazars GR, et al: p53 and RAS gene mutations in multiple myeloma. Oncogene 7:2539-2543, 1992
-
(1992)
Oncogene
, vol.7
, pp. 2539-2543
-
-
Portier, M.1
Moles, J.P.2
Mazars, G.R.3
-
5
-
-
0027505575
-
p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy
-
Neri A, Baldini L, Trecca D, et al: p53 gene mutations in multiple myeloma are associated with advanced forms of malignancy. Blood 81:128-135, 1993
-
(1993)
Blood
, vol.81
, pp. 128-135
-
-
Neri, A.1
Baldini, L.2
Trecca, D.3
-
6
-
-
0029153427
-
N-ras and p 53 gene mutations are very rare events in multiple myeloma
-
Yasuga Y, Hirosawa S, Yamamoto K, et al: N-ras and p53 gene mutations are very rare events in multiple myeloma. Int J Hematol 62:91-97, 1995
-
(1995)
Int J Hematol
, vol.62
, pp. 91-97
-
-
Yasuga, Y.1
Hirosawa, S.2
Yamamoto, K.3
-
8
-
-
0032147210
-
Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy
-
Drach J, Ackermann J, Fritz E, et al: Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy. Blood 92:802-809, 1998
-
(1998)
Blood
, vol.92
, pp. 802-809
-
-
Drach, J.1
Ackermann, J.2
Fritz, E.3
-
9
-
-
0030612728
-
INK4A are preferentially expressed in immature and mature myeloma cells, respectively
-
INK4A are preferentially expressed in immature and mature myeloma cells, respectively. Brit J Haematol 99:131-138, 1997
-
(1997)
Brit J Haematol
, vol.99
, pp. 131-138
-
-
Kawano, M.M.1
Mahmoud, M.S.2
Ishikawa, H.3
-
10
-
-
0034212785
-
Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p 21, and apoptosis
-
Park WH, Seol JG, Kim ES, et al: Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Cancer Res 60:3065-3071, 2000
-
(2000)
Cancer Res
, vol.60
, pp. 3065-3071
-
-
Park, W.H.1
Seol, J.G.2
Kim, E.S.3
-
11
-
-
0030921866
-
MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells
-
Teoh G, Urashima M, Ogata A, et al: MDM2 protein overexpression promotes proliferation and survival of multiple myeloma cells. Blood 90:1982-1992, 1997
-
(1997)
Blood
, vol.90
, pp. 1982-1992
-
-
Teoh, G.1
Urashima, M.2
Ogata, A.3
-
12
-
-
0031840937
-
waf-1, and Ki-67 in multiple myeloma: Correlation with cyclin D 1 immunoreactivity
-
waf-1, and Ki-67 in multiple myeloma: Correlation with cyclin D1 immunoreactivity Mod Pathol 11:642-647, 1998
-
(1998)
Mod Pathol
, vol.11
, pp. 642-647
-
-
Lai, R.1
Medeiros, L.J.2
Wilson, C.S.3
-
13
-
-
0029849620
-
Cancer cell cycles
-
Sherr CJ: Cancer cell cycles. Science 274:1672-1677, 1996
-
(1996)
Science
, vol.274
, pp. 1672-1677
-
-
Sherr, C.J.1
-
14
-
-
0028986932
-
kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors
-
kip1: Chromosomal mapping to 12p12-12p13.1 and absence of mutations in human tumors. Cancer Res 55:1211-1214, 1995
-
(1995)
Cancer Res
, vol.55
, pp. 1211-1214
-
-
Ponce-Castaneda, M.V.1
Lee, M.H.2
Latres, E.3
-
16
-
-
0032923368
-
Cyclin E in human cancers
-
Donnellan R, Chetty R: Cyclin E in human cancers. FASEBJ 13:773-780, 1999
-
(1999)
FASEBJ
, vol.13
, pp. 773-780
-
-
Donnellan, R.1
Chetty, R.2
-
17
-
-
0032147113
-
Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas: Prognostic implications
-
Erlanson M, Portin C, Linderholm B, et al: Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas: Prognostic implications. Blood 92:770-777, 1998
-
(1998)
Blood
, vol.92
, pp. 770-777
-
-
Erlanson, M.1
Portin, C.2
Linderholm, B.3
-
19
-
-
0033838792
-
Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14)
-
Pruneri G, Fabris S, Baldini L, et al: Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). Am J Pathol 156:1505-1513, 2000
-
(2000)
Am J Pathol
, vol.156
, pp. 1505-1513
-
-
Pruneri, G.1
Fabris, S.2
Baldini, L.3
-
20
-
-
0016804136
-
A clinical staging system for multiple myeloma
-
Durie BGM, Salmon S: A clinical staging system for multiple myeloma. Cancer 36:842-854, 1975
-
(1975)
Cancer
, vol.36
, pp. 842-854
-
-
Durie, B.G.M.1
Salmon, S.2
-
21
-
-
0023125752
-
Histologic classification and staging of multiple myeloma: A retrospective and prospective study of 674 cases
-
Bartl R, Frisch B, Fateh-Moghadam A, et al: Histologic classification and staging of multiple myeloma: A retrospective and prospective study of 674 cases. Am J Clin Pathol 87:342-355, 1987
-
(1987)
Am J Clin Pathol
, vol.87
, pp. 342-355
-
-
Bartl, R.1
Frisch, B.2
Fateh-Moghadam, A.3
-
22
-
-
0030887695
-
Standard therapy - Versus autologous transplantation in multiple myeloma
-
Attal M, Harousseau JL: Standard therapy - versus autologous transplantation in multiple myeloma. Hematol Oncol Clin North Am 11:133-146, 1997
-
(1997)
Hematol Oncol Clin North Am
, vol.11
, pp. 133-146
-
-
Attal, M.1
Harousseau, J.L.2
-
23
-
-
0030805232
-
MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: Association with wild-type p53 accumulation
-
Pruneri G, Pignataro L, Carboni N, et al: MDM-2 oncoprotein overexpression in laryngeal squamous cell carcinoma: Association with wild-type p53 accumulation. Mod Pathol 10:785-792, 1997
-
(1997)
Mod Pathol
, vol.10
, pp. 785-792
-
-
Pruneri, G.1
Pignataro, L.2
Carboni, N.3
-
25
-
-
12944283204
-
Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma
-
Chiarle R, Budel LM, Skolnik J, et al: Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood 95:619-626, 2000
-
(2000)
Blood
, vol.95
, pp. 619-626
-
-
Chiarle, R.1
Budel, L.M.2
Skolnik, J.3
-
26
-
-
0035751937
-
Assessing TP53 status in human tumours to evaluate clinical outcome
-
Soussi T, Beroud C: Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 1:233-240, 2001
-
(2001)
Nat Rev Cancer
, vol.1
, pp. 233-240
-
-
Soussi, T.1
Beroud, C.2
-
27
-
-
0028236846
-
Induction of WAF1/CIP1 by a p53-independent pathway
-
Michieli P, Chedid M, Lin D, et al: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391-3395, 1994
-
(1994)
Cancer Res
, vol.54
, pp. 3391-3395
-
-
Michieli, P.1
Chedid, M.2
Lin, D.3
-
28
-
-
0036247821
-
p53-Mdm2 - The affair that never ends
-
Alarcon-Vargas D, Ronai Z: p53-Mdm2 - the affair that never ends. Carcinogenesis 23:541-547, 2002
-
(2002)
Carcinogenesis
, vol.23
, pp. 541-547
-
-
Alarcon-Vargas, D.1
Ronai, Z.2
-
29
-
-
0032417695
-
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
-
Jones SN, Hancock AR, Vogel H, et al: Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci U S A 95:15608-15612, 1998
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 15608-15612
-
-
Jones, S.N.1
Hancock, A.R.2
Vogel, H.3
-
30
-
-
0026649648
-
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
-
Momand J, Zambetti GP, Olson DC, et al: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245, 1992
-
(1992)
Cell
, vol.69
, pp. 1237-1245
-
-
Momand, J.1
Zambetti, G.P.2
Olson, D.C.3
-
31
-
-
0027325132
-
Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53
-
Oliner JD, Pietenpol J, Thiagalingam S, et al: Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857-860, 1993
-
(1993)
Nature
, vol.362
, pp. 857-860
-
-
Oliner, J.D.1
Pietenpol, J.2
Thiagalingam, S.3
-
32
-
-
0032145989
-
The MDM 2 gene amplification database
-
Momand, J, Jung D, Wilczynski S, et al: The MDM2 gene amplification database. Nucleic Acids Res 26:3453-3459, 1998
-
(1998)
Nucleic Acids Res
, vol.26
, pp. 3453-3459
-
-
Momand, J.1
Jung, D.2
Wilczynski, S.3
-
33
-
-
0027368879
-
The human MDM-2 oncogene is overexpressed in leukemias
-
Bueso-Ramos CE, Yang Y, deleon E, et al: The human MDM-2 oncogene is overexpressed in leukemias. Blood 82:2617-2623, 1993
-
(1993)
Blood
, vol.82
, pp. 2617-2623
-
-
Bueso-Ramos, C.E.1
Yang, Y.2
Deleon, E.3
-
34
-
-
0027337423
-
Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes
-
Preudhomme C, Quesnel B, Vachee A, et al: Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes. Leukemia 7:1291-1293, 1993
-
(1993)
Leukemia
, vol.7
, pp. 1291-1293
-
-
Preudhomme, C.1
Quesnel, B.2
Vachee, A.3
-
35
-
-
0028286492
-
Lack of MDM2 amplification in human leukaemia
-
Ridge SA, Dyer M, Greaves MF, et al: Lack of MDM2 amplification in human leukaemia. Brit J Haematol 86:407-409, 1994
-
(1994)
Brit J Haematol
, vol.86
, pp. 407-409
-
-
Ridge, S.A.1
Dyer, M.2
Greaves, M.F.3
-
36
-
-
0030032584
-
mdm-2 oncogene expression in non-Hodgkin's lymphomas
-
Kawamata N, Miller C, Levy V, et al: mdm-2 oncogene expression in non-Hodgkin's lymphomas. Diagn Mol Pathol 5:33-38, 1996
-
(1996)
Diagn Mol Pathol
, vol.5
, pp. 33-38
-
-
Kawamata, N.1
Miller, C.2
Levy, V.3
-
37
-
-
0032568334
-
Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells
-
Capoulade C, Bressac-de Paillerets B, Lefrere I, et al: Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells. Oncogene 16: 1603-1610, 1998
-
(1998)
Oncogene
, vol.16
, pp. 1603-1610
-
-
Capoulade, C.1
Bressac-de Paillerets, B.2
Lefrere, I.3
-
38
-
-
0031939875
-
Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage
-
Chen L, Agrawal S, Zhou W, et al: Synergistic activation of p53 by inhibition of MDM2 expression and DNA damage. Proc Natl Acad Sci U S A 95:195-200, 1998
-
(1998)
Proc Natl Acad Sci U S A
, vol.95
, pp. 195-200
-
-
Chen, L.1
Agrawal, S.2
Zhou, W.3
-
39
-
-
0035865516
-
Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides
-
Capoulade C, Mir LM, Carlier K, et al: Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides. Blood 97:1043-1049, 2001
-
(2001)
Blood
, vol.97
, pp. 1043-1049
-
-
Capoulade, C.1
Mir, L.M.2
Carlier, K.3
-
40
-
-
0035204480
-
Expression of cyclin E and cyclin D1 in non-small cell lung cancers
-
Yamanouchi H, Furihata M, Fujita J, et al: Expression of cyclin E and cyclin D1 in non-small cell lung cancers. Lung Cancer 31:3-8, 2001
-
(2001)
Lung Cancer
, vol.31
, pp. 3-8
-
-
Yamanouchi, H.1
Furihata, M.2
Fujita, J.3
-
41
-
-
0035122539
-
Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications
-
Donnellan R, Kleinschmidt I, Chetty R: Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications. HUM PATHOL 32:89-94, 2001
-
(2001)
Hum Pathol
, vol.32
, pp. 89-94
-
-
Donnellan, R.1
Kleinschmidt, I.2
Chetty, R.3
-
43
-
-
0027283604
-
Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents
-
Lotem J, Sachs L: Hematopoietic cells from mice deficient in wild-type p53 are more resistant to induction of apoptosis by some agents. Blood 82:1092-1096, 1993
-
(1993)
Blood
, vol.82
, pp. 1092-1096
-
-
Lotem, J.1
Sachs, L.2
|